Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Shanghai Creation Investment

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 7
Rounds per year 0.44
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 2
Key employees 3

Areas of investment

  • Manufacturing
  • Biotechnology
  • Medical
  • Medical Device
  • Health Diagnostics
Summary

Shanghai Creation Investment appeared to be the VC, which was created in 2006. The leading representative office of defined VC is situated in the Shanghai. The venture was found in Asia in China.

The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Shanghai Creation Investment performs on 4 percentage points less the average number of lead investments. The common things for fund are deals in the range of 5 - 10 millions dollars.

The standard case for the fund is to invest in rounds with 3 partakers. Despite the Shanghai Creation Investment, startups are often financed by General Technology Venture Capital. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Waarde Capital, Robert Bosch Venture Capital. In the next rounds fund is usually obtained by Avacare Health Group.

Among the most successful fund investment fields, there are Energy, Clinical Trials. For fund there is no match between the location of its establishment and the land of its numerous investments - Israel. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Biop-Medical, Cygnus Biosciences. The fund has exact preference in a number of founders of portfolio startups.

We also calculated 3 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Shanghai Creation Investment:
Typical Co-investors
Shanghai Creation Investment is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Shanghai Creation Investment:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Akron Archangels Akron, Ohio, United States
Amer International Group China, Guangdong, Shenzhen
Blumenstein/Thorne Information Partners Illinois, Lake Forest, United States
Darling Ventures California, San Francisco, United States
Delaney Capital United States, Washington, Yakima
Gramercy Ventures California, San Francisco, United States
James Richardson & Sons Canada, Manitoba, Winnipeg
Kuka Home China, Hangzhou, Zhejiang
LANXESS Cologne, Germany, Nordrhein-Westfalen
LifeForce Capital California, San Francisco, United States
Marelli Japan, Saitama, Saitama Prefecture
Mimecast -
Next Level Ventures Des Moines, Iowa, United States
Nextel Communications Kansas, Overland Park, United States
Nippon Rent-A-Car Japan, Miyakojima, Okinawa Prefecture
Rasmuson Foundation Alaska, Anchorage, United States
Resonant Venture Partners Ann Arbor, Michigan, United States
Woomi construction corporation -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Meio Medical

Health Care
Manufacturing
Medical
Medical Device
14 Aug 2023 Hangzhou, Zhejiang, China

Shende Medical Equipment Technology

Biotechnology
Manufacturing
Medical
Medical Device
$15M14 Dec 2021 Shanghai, Shanghai, China

Shende Medical Equipment Technology

Biotechnology
Manufacturing
Medical
Medical Device
$15M06 Jul 2021 Shanghai, Shanghai, China

Simcere Pharma

Biotechnology
Manufacturing
$92M04 Jun 2021 Xuanwu District, Jiangsu, China

Cygnus Biosciences

Biotechnology
Clinical Trials
Health Diagnostics
Pharmaceutical
Therapeutics
$19M14 Nov 2017 Changping District, Beijing, China

Biop-Medical

Health Care
Health Diagnostics
Medical
$2M06 Apr 2016 North District

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Shanghai Creation Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 19M
Rounds per year 0.44
Peak activity year 2016
Lead investments 3
Follow on index 0.12
Exits 2
Group Appearance index 0.62

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Meio Medical

Health Care
Manufacturing
Medical
Medical Device
14 Aug 2023 Hangzhou, Zhejiang, China

Shende Medical Equipment Technology

Biotechnology
Manufacturing
Medical
Medical Device
$15M14 Dec 2021 Shanghai, Shanghai, China

Shende Medical Equipment Technology

Biotechnology
Manufacturing
Medical
Medical Device
$15M06 Jul 2021 Shanghai, Shanghai, China

Simcere Pharma

Biotechnology
Manufacturing
$92M04 Jun 2021 Xuanwu District, Jiangsu, China

Cygnus Biosciences

Biotechnology
Clinical Trials
Health Diagnostics
Pharmaceutical
Therapeutics
$19M14 Nov 2017 Changping District, Beijing, China

Biop-Medical

Health Care
Health Diagnostics
Medical
$2M06 Apr 2016 North District
Crunchbase icon

Content report

The following text will be sent to our editors: